Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance
Oestrogen receptor alpha (ER; gene symbol ESR1) is the most important prognostic and treatment‐predictive biomarker in breast cancer. Drugs targeting oestrogen and ER for endocrine therapy of breast cancer include aromatase inhibitors, the selective ER modulator tamoxifen and the selective ER degrad...
Saved in:
Main Authors: | Juliane Albrecht, Mirjam Müller, Völundur Hafstað, Kamila Kaminska, Johan Vallon‐Christersson, Gabriella Honeth, Helena Persson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13713 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis
by: Yitian Lang, et al.
Published: (2025-01-01) -
Association Between Body Mass Index, Abdominal Obesity and Menopause-Related Symptoms in Postmenopausal Women
by: Brianna A Rice, et al.
Published: (2024-12-01) -
Gender-affirming hormone therapy: effects on cardiovascular risk and vascular function
by: Kirsty A McGinley, et al.
Published: (2025-01-01) -
The role of oestrogen and oestrogen-calcium axis in endometrial carcinoma
by: Jingyi Zhou, et al.
Published: (2024-04-01) -
The relationship between mutation carriage of BRCA1/2 and clinicopathological characteristics in women with breast cancer – experience from a diagnostic centre in Turkey
by: Neslihan Duzkale, et al.
Published: (2024-09-01)